Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
The Air Force is yanking most of its biggest programs out from its existing program-management structure and putting them under a new four-star who reports to the deputy defense secretary. On Tuesday, ...
For decades, data centers were designed with permanence in mind: fixed plans, rigid shapes and predictable life cycles. Physical constraints of legacy architectures made them inherently static. But in ...
Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...
The shift from passive to proactive AI is underway — and it's moving faster than most enterprises can adapt. In fact, Gartner projects that at least 15% of work decisions will be made autonomously by ...
They promise discounts on gas, groceries and more — but at what cost? Retail loyalty programs offer tempting perks yet often come with a hidden price: your privacy. A new Consumer Reports ...
WASHINGTON, September 30 - Market-sensitive commodity data reports released by the U.S. Department of Agriculture and nutrition programs that feed millions of Americans could be vulnerable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback